Known as Rejoyn, the treatment is a smartphone app that's designed to be used along with antidepressant medications. "Rejoyn represents a novel and exciting adjunctive treatment option to address ...
Marketed as Rejoyn, the app provides a six-week treatment program designed to help enhance mood regulation through a combination of emotional training exercises for the brain, brief therapeutic ...
Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...